Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Exercise improved QoL, functioning in breast cancer survivors
- Author:
- Sharon Worcester
Publish date: November 8, 2019
News
Better overall survival with nivolumab vs. chemo for advanced ESCC
- Author:
- Sharon Worcester
Publish date: November 7, 2019
News

Nivolumab benefit for NSCLC persists at 5-year follow-up
- Author:
- Sharon Worcester
Publish date: November 6, 2019
News
Case-control study IDs several novel risk factors of post-HCT melanoma
- Author:
- Sharon Worcester
Publish date: November 6, 2019
News

Immune checkpoint inhibition in SCLC: Modest outcomes, many questions
- Author:
- Sharon Worcester
Publish date: November 4, 2019
News

New data further define role of PD-L1 status, immunotherapy in metastatic breast cancer
- Author:
- Sharon Worcester
Publish date: October 31, 2019
News

Consider renal function in TLS risk assessment of venetoclax-treated CLL
- Author:
- Sharon Worcester
Publish date: October 29, 2019
News

Soccer pros may face increased risk of death from neurodegenerative disease
- Author:
- Sharon Worcester
Publish date: October 21, 2019
News

Adding veliparib to chemotherapy improves PFS in BRCA-mutated breast cancer
- Author:
- Sharon Worcester
Publish date: October 21, 2019
News

Veliparib improves PFS in high-grade serous epithelial ovarian cancer
- Author:
- Sharon Worcester
Publish date: October 17, 2019
News

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
- Author:
- Sharon Worcester
Publish date: October 16, 2019
News
Nivolumab boosts overall survival in HCC
- Author:
- Sharon Worcester
Publish date: October 14, 2019
News

PRIMA study: Niraparib maintenance improves PFS in advanced OC
- Author:
- Sharon Worcester
Publish date: October 8, 2019
News
mIDH1 inhibitor ivosidenib improves progression-free survival in advanced cholangiocarcinoma
- Author:
- Sharon Worcester
Publish date: October 1, 2019
News

MONARCH 2: Abemaciclib plus fulvestrant improves overall survival
- Author:
- Sharon Worcester
Publish date: October 1, 2019